FDA approves new breakthrough migraine treatment


U.S. (WIAT) — It’s being called a breakthrough for those who suffer from migraines. 

A new FDA approved treatment called Emgality is the third in a class of new drugs that aim to stop the headaches before they begin. 

Emgality is a once per month treatment. it binds wih a substance of the brain that may cause migraines. Officials report, there are no major side effects.

The drug costs about $575 per month. The company, Lily, is offering some sufferers their first year of doses for free. 

Copyright 2019 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories

CBS 42 Community Events

More CBS 42 Community Events